According to a national study published in The Journal of Hepatology, close relatives of persons with metabolic-associated fatty liver disease had a greater chance of acquiring liver cancer and dying from liver-related disorders. According to the researchers, this suggests that family member
Resistant starch is a nondigestible fibre that ferments in the large intestine, and it has previously been demonstrated in animal experiments to have a favourable effect on metabolism. A 4-month randomised controlled experiment in persons with non-alcoholic fatty liver disease (NAFLD) has fo
According to a study presented at the Endocrine Society's annual meeting in Chicago, the percentage of adults suffering from metabolic-associated fatty liver disease (MAFLD), the leading cause of liver disease worldwide, is increasing.
According to a study presented at ENDO 2023, the Endocrine Society's annual meeting in Chicago, the percentage of adults with metabolic-associated fatty liver disease (MAFLD), the major global cause of liver disease, is growing.
According to a study presented Friday at ENDO 2023, the Endocrine Society's annual meeting in Chicago, the percentage of adults with metabolic-associated fatty liver disease (MAFLD), the major global cause of liver disease, is growing.
The Union Ministry of Health and Family Welfare on Thursday organized a webinar on Non-Alcoholic Fatty Liver Diseases (NAFLD) to empower medical officers of Primary Health Centres (PHCs), Community Health Centres (CHCs) and District Hospitals.
Researchers discovered that cancer frequently sends substances into the bloodstream that pathologically alter the liver, putting it in an inflammatory condition, causing fat to build up, and interfering with its regular detoxification functions.
Researchers at Weill Cornell Medicine found that cancer often releases molecules into the bloodstream that pathologically modify the liver, sending it into an inflammatory state, causing fat accumulation, and disrupting its typical detoxification processes. This finding sheds light on one of
Autoaggressive T cells cause inflammatory fatty liver disease (NASH, nonalcoholic steatohepatitis) and the ensuing liver cancer. Scientists from the German Cancer Research Centre (DKFZ) have finally discovered the cause of this harmful behaviour. They discovered an increase in the number of
A study has revealed that metabolic (bariatric) surgery is more effective than medications for the treatment of advanced non-alcoholic fatty liver disease.
A study has found that metabolic (bariatric) surgery is more effective than medications for the treatment of advanced non-alcoholic fatty liver disease.